Atlas Trials

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

Clinical trial NCT02302092 · TERMINATED

Trial details

NCT number
NCT02302092
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Urinary Tract Infection
Start date
2015-12-01
Primary completion
2016-02-02
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.